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C utaneous mast cell s from 3 patients with mastocytosis 
were evaluated for their morphologic.: characteristics and in 
vitro functional reactivities to different secretory agonists. 
By electron microscopy, mastocytosis mast cells appeared 
large r than normal skin m ast cells, frequently had atypical, 
highly indented or bilobed nuclei, and each contai ned nu-
merous , elonga ted cytopl as mic proj ections. Suspensions of 
mastocytosis m ast cells were o btained from les ional skin 
biopsy specimens, and their response to both immun ologic 
and nonimmunologic secretagogues was compared w ith 
mast cells from normal skin. Lesional skin mast cell s had 
a net histamine release of 12.3% ( ± 1. 3 SEM) and 31.1 % 
(± 6.0 SEM) following stimulation with the purified hu-
man anaphylotoxin C3, and mouse monoclonal antihum an 
M astocy tosis represents a spectrum disorder re-sulting from an abnormal proliferation of t. iss u.e mast cells. The fea tures of this disease process have been th e subj ect of null1 erous repo rts 11-7]. . In particular , several stud ies have fo cused o n the 
atypica l morphologic chara cteristics of m as t cells in cutaneous 
lesions of mastocytosis at th e ultrastru ctural lcvel 18-1 2]. Because 
of this morphologic atypia, the functional reactivities o f mast cells 
fro m patients w ith mastocy tosis have been ques ti oned 11 0]. Al-
though the occurrence of both loca l cutaneous and systemic mast 
cell- mediated sy mptoms is well documented in patients w ith 
mastocytos is [2-4,13,14], we have been impressed that m ost of 
the mastocytosis patients under our care have few clini ca l com-
plaints. Th is observation also has led us to question the respon-
siveness of m ast cells from som e patients with mastocytosis to 
different stimuli. 
O ur ongoi ng interest in hum an m as t cell fun ction has resulted 
in the development of a technique for obtain ing viable, normal 
human cutaneous mast cells in suspension for in vit ro fun ctional 
studies [1 5, 16]. In this report, we have applied this isolation method 
to lcsional skin biopsy specimens from 3 patients w ith masto-
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Abbreviation: 
FCS: fetal ca lf serum 
IgE antibodies, respectively. This specifi c release was sim-
il ar to the responses observed in no rm al skin mast cells 
(1 1. 5% ± 4.5 SEM and 16.7% ± 2.] SEM , respectively) . 
Mast cell s from cutaneous lesions of mastocytos is also re-
sponded to the nonimmunologic secretagogues, morphine 
sulfate and calcium io nophorc A23187 with a specific his-
tamine release of 15 .1% (± 1. 2 SEM) and 39.8% (± 8.7 
SEM) , respecti vely. The results of this stud y demonstrate 
that mast cell s from les ions of mastocytosis are morpho-
logica ll y atypical, but have a hi stamine content similar to 
normal skin m ast cell s and retain their functional reactiv-
ities to clinically relevant secretory stimuli. J In vest Dermatof 
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cytosis, and have examined the resultin g mast cel l suspensions 
for their in vitro res ponses to secretory agonists. In addition, we 
have assessed the morphologic characteristi cs of Ie siona I skin mast 
cells from these 3 patiellts by electron mi croscopy and have com-
pared these fea tures w ith mast cell s in normal skin. O ur results 
confi rm prev io us observations that mast cells in cutaneous lesions 
of m astocytosis are morpholo gicall y atypical by several param-
eters. H owever, despite these m o rphologic alterations , masto-
cytosis lll ast cell s are similar to no rmal ski n mast cell s in their in 
vitro responses to different secreto ry stimuli. 
MATERIALS AND METHODS 
Reagents Histamine dih yd rochlo ride, N-2-h ydrox yethylpiper-
azine-N'-2-eth anes ulfonic acid (HEPES) , hUlll an serum albumin 
frac tion V, porcine intes tinal heparin , po rcine kidney diamine 
ox idase (hi staminase) , gentamicin , hyaluronid ase, deoxy ribonu-
clease (D N ase), and ca lcium ionophore A23187 (S ig ma C hemical 
Co., St. Louis, Missouri); collagenase (Type III ) (Wo rthin gton, 
Freehold , New Jersey); feta l ca lf seru m (FCS) , Alpha m edium , 
L-glutamine, ant ibiotic- anti m yo ti c mixture (GIBCO Laborato-
ries, Grand Island , N ew York); m o rphi ne sulfate (Merck, Rah-
way, N ew Jersey); and [3H]-S-adenosy l-methionin e (76 C i/ mM) 
(Amcrs ham , Arlin g ton Heights, Illinois) were purchased from 
the sources ci ted. Mouse m onoclonal antihum an IgE antibodie 
and purified hum an C3, were the generous gifts of Dr. J. Donald 
Ca pra, University of Texas H ea lth Science Center, Da ll as, T exa 
and Dr. Tony Hu gli , Scripps C lini c and Resea rch Foundation , 
La Jo lla, Ca lifo rnia. 
Preparation of Human Cutaneous Mast Cell Suspensions 
Discarded hum an cutaneous tissue was obtained foll owing cir-
cum cision of in fan ts rangin g in age from 3 da ys to 6 years. Fol-
lowing informed consent , shaved lesional sk in specimens were 
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o btained after intradermal anesthesia with 1 % lidocaine from 2 
a dult patients with the telangiectatic lesions of mastocytosis (pa-
tients 1 and 2) and a four-year-old child with papular lesions of 
mastocytosis (patient 3). All cutaneous specimens were placed 
immediately in Alpha medium, stored at 4°C and used wlthm 2 
h. A mixed suspension of dermal cells was prepared usmg a 
modified method as described previously [16]. Skin specimens 
were weighed and cut into 200-ILm thick sli ces, washed twice in 
15 ml of buffer (135 mM NaCI , 3 .7 mM KCI, 5 mM NaY04, 1.5 
m M CaCI2, 0.5 mM MgC I2' 25 mM HEPES, 5 mM g lucose, hep-
arin (7 ILg/ ml) , pH 7.2) , and added to 10 ml scintillation vials 
containing a buffer solution of coll agenase (0.2 units/ml) , hyal-
uronidase (0.2 units/ml), and DNase (0.5 m g/ml). Indi vid ual cells 
were harves ted from tiss ue slices by pass ing the mixture over a 
fme mesh n ylon screen. Cells were washed twi ce in 15 ml of ice 
cold buffer and res uspended for overnight culture in conditIOned 
Alpha m edium of2 mM L-glutamine, 25 mM HEPES, gentamicin 
(10 ILg/ ml) , antibiotic-an tim ycotic mixture (20 ILI/ml) , and 10% 
h eat in ac tivated FCS. Passive sensiti za tion of m as t cells was ac-
complished by ovcrnight incubation in condition ed Alpha mc-
diu m with 10% human scrum containing 4.4 m g/ ml of IgE. 
Sam ple aliquots of m as t cells recovered from overnig ht cultures 
w ere staincd w ith crys tal violet, conju ga ted avidin , and trypan 
blue. Human cutaneous mast cells wcre readil y differentiated from 
o ther disaggrcgated derma l cclIs by their num crous cyto plasmic, 
m etachro m ati c gra nulcs and their abi li ty to bind conjuga ted av-
idin [1 51. An averagc of3.06 X 102 m as t cells/ mg of no rm al skm 
and 2.25 X 10.1 m as tocy tosis m as t cells/m g o f leslOnal tissue 
re p resentin g 13.2% (± 0.8 SEM) and 80.5% (± 5.0 SEM), re-
sp ectively, of the to tal dermal cell population was routmcIy re-
covered. The mean m as t cell viability fr0111 all specimens after 
o vernight culture was 85.6% (± 1.9 SEM) as determined by 
trypan blue exclusio n. 
Experimental Procedure for In Vitro Studies Approxi-
m a tely 3000 m as t cells in 0.05 ml of buffer were in cubated from 
15- 30 min at 37°C in a 12 X 100 mm po lycarbonate tube With 
an equa l vo lume of buffer alo ne, buffer containin g ca lcium ion-
o p hore A231 87 (3 ILg / ml), C3" (1 ILM) o r m o rphine sul fa te (10 
f.LM). Cells pass ively sensitized overnight we re stimulated under 
th e sa m e conditions with m o use monoclona l an tihum an IgE an-
tibodies as previo usly described [1 6, 17]' Each experimental con-
d ition was perfo rm ed in triplica te. M as t cell stimulation was ter-
m ill ated by addin g 0.4 ml of ice co ld buffer to IIldl vldual tubes 
tha t had been plunged in an ice wa ter bath. T he in cuba~ i on su-
perna tants were aspirated fr o m th e cell suspension fo llowlJ1g cen-
trifuga tion (200 g) for 7 min at 4°C. The reSidual 11lStamlll e III 
each sa mple was ex tracted by resuspending the cells 11l 1 . .0 ml o f 
b uffer and hea tin g at 10rC in a hea tin g block for .10 mJl1. Fol-
lowing in cubation w ith va ryin g agonists, suspenSIOns of mas t 
cells were exa min ed microscopi ca ll y for their ability to exclude 
rr ypan blue (0. 1 %) and compared with buffer contro ls. N o dif-
fe ren ce in mast cell viability (82.3% ± 3.0 SEM) was detected 
among the different experim ental co nditions. 
Histamine Assay Hi stamine released from cutaneous mas t cells 
w as measured by a modifi ed sin gle radioenzy matic method based 
on the work of Snyder et al [18]. Histamin e N-methyltransferase 
w as prepared from Sprague-Dawley rat kidn eys using a modIfied 
purifica tion scheme o f Verb erg et al [1 9]. D upli cate samples from 
each stimul ated supernatant an d from each res idual cell pellet were 
assayed for histamin e as previo usl y descr ibed [1 6,171. Stan dard 
cu rves for added authentic histamine (10-1000 pg) were deter-
mjned for each assa y. Correlatio n coeffi cients derived from linear 
reg ress ion analys is of th e standard histamin e curves ran ged from 
0. 98- 0.99. The presence of putative hi stamine In ex perImental 
sa mples was confirm ed by degradati on with porcine histamlll ase 
as described previously [1 7J. In all experIm ents the histamlll e III 
the supern atant and the res idu al cellul ar his tamine in each sample 
w er e added to determin e the tota l histamllle present. The super-
na tant histamin e was divided by the tota l histamin e content m 
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each sa mple to determine th e percent histamine rel eased during 
ex perimental conditions. 
Electron Microscopic Studies Representative samples of all 
ti ssue spccimens we re initi all y immersion-fixed in a solu tion con-
tainin g 1 % g lutara ldehyde and 2% parafo rm aldeh yde III 0 .1 M 
cacod ylate buffer w ith 0.125 M sucrose and 0.005 M CaCh (pH 
7.2). Tissues were trimmed into small StripS for OrIentatIOn and 
fi xed for 4 h at 4°C. Fol lowin g a buffer rin se, specimens were 
pos tfi xed in 1 % os mium tetroxide buffered in 0. 1 M cacod ylate 
(pH 7.2) for 2 h . Fixed sa mples were deh ydrated m a g raded serIes 
of eth anol, followed by pro pylene OXide and embedded m epoxy 
plastic (Poly/Bed 812, Polysciences, Warrin gton, Pennsylvallla) . 
For microscopy , embedded specimens were on ented and g lued 
on prepolymerized blocks so that sectIOns were cut perpendicular 
to th e upper derm al surface. For light microscopy, l-:lLm seCtIons 
were prepared on an LKB ultratome and stamed w ith tolUJdme 
blue. Mas t cell loca tions were Identified 111 th e dermiS, and tissue 
blocks were trimmed for electron microscopy . Sections (40- 60 
nm) were cut with a diamond knife, m ounted on coHodian-coated 
g rids , stained with uranyl ace tate and lead Citrate, and Viewed 
with a Joel 100 C X electron microscope. All dermal m as t cells 
were photographed at 2000 x , the prints were enlarged to 5600 x , 
and th e cells were assessed for their morphologiC characterIstics . 
RESULTS 
Morphology of Mast Cells in Lesions of Mastocytosis M as t 
cell m orpho logy in cutaneous lesions of m as tocy tosIs and normal 
skin was assessed by electron microscop y. In no rmal cutaneous 
specimens these dermal cells appea red round to . ova l in shape, 
had slightl y oval nuclei, and numerous cyto plasm.lc g ranules (Fig 
1). In contrast, Iesional skin mast cells from patient 1 appea red 
larger than norm al, w ere irregul ar in overall shape, and frequ entl y 
had bil obed nucl ei (Fig 2). Numerous elonga ted cy to pl asm iC pro-
jections were ev ident in these cells. An apparcnt 111crease m th e 
number and len g th of cytoplasmic extensIOns and g ranule size 
was observed in the Iesional skin mast cells from patient 2, w hereas 
in patient 3 large m as t cells often had bil obed nuclei, and nu-
mero us atyp ical cytoplasmi c projections (data no t shown). 
In Vitro Functional Reactivities of Skin Mast Cells From 
Mastocytosis Patients Suspensions of Iesio nal skin n~as t cells 
from each patient w ith mastocytosIs were exam11led tor th elf 
Figure 1. Human mast cell fro m l1 o rl11.31 skin with charactnisric ova l-
shaped nucleus. 
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Figure 2. Lesional sk in mast cell fro m mastocytosis patient 1. Note the 
irrcgul;lr cel l shape. elongated cytopbsmic ex tensions Jnd bilobed nu-
cleus. 
histamin e conten t and ability to res pond in vit ro to secretory 
agonists. T he average mast cell histamine concent ration amon g 
the 3 different patients ranged frol11 3.2 (± 0. 1 SEM) pg to 4.2 
(± 0.6 SEM) pg per cell , w hereas a mean no rm al sk in m as t cell 
hi stamine content of 4. 1 (::t 0.8 SEM) pg was observed (Ta-
ble I). 
Usin g histamine release as an indi cator of mast cell stim ulation , 
the in vitro fun ctiona l rea cti vities of Ill as t cell s from lesions of 
mastocytosis an d no rm al sk in were in ves ti ga ted . C utaneous mast 
cell sll spensions frOI11 each patient were in cubated w ith the non-
immunologic secretagogue, calcium ionopho re A23187 (3 J,Lg/ ml). 
or buffer contro l fo r 15 min at 37°C, and their response was 
co mpared w ith norm al skin mast cell s. In all 3 patient Ill as t cell 
preparations, signifi ca nt hista mine release above buffer contro ls 
was detectab le, and in patients 2 and 3 this in vitro response was 
grea ter than normal skin mast cell s (Table I). Suspensions of mas t 
cell s from patient 3 and from norm al skin also were challenged 
with the secreto ry agoni st, morph ine sul fa te (10 J,L M) . Within 15 
min , mastocytosis mast cell s demonstra ted a net hi stam ine re lease 
of 15. 1 % (± 1.2 SEM ) abo ve buffer co ntro ls, w hereas mast cel ls 
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fro m norm al skin specifi ca ll y released 9.4% (± 1.1 SEM ) of their 
tota l histami ne content after morph ine st imulatio n, 
M ast cel ls fro m all 3 patients w ith m astocytos is also were in-
vestigated for their ability to respond to 3n immunologic stim-
ulus. Due to limi ted cell numbers , lcsio nal sk in m ast cell s were 
challen ged w ith either the purifi ed hum an anaph ylotox in , C3, (1 
j.L M), or with mo use monoclonal antihuman IgE antibodies. M ast 
cell s fro m patients 1 and 2 released histamine (22 .7% ± 1.3 SEM 
and 19.6% ± 1. 3 SEM , res pecti vel y) in response to C3 .• stim u-
lation . This reactivity was very similar to C3,,-induced histamine 
release fro m !lo nll al sk in mast cell s (19% ± 4.5 SEM) (Table I). 
Mast cells fro m patient 3 were pass ively sensitized overni ght w ith 
hum an IgE and examin ed fo r the presence o f fun ctio nal IgE re-
ceptors. Followin g cha llenge w ith allti-l gE antibo dies, signifi cant 
histall1.ine release (41.2% ± 6.0 SEM) from these cel ls was ob-
se rv ed (Table I). 
D ISC U SS ION 
Interes t in lesio nal sk in m ast cells fro m patients w ith m astocy tosis 
has resulted in a number of reports describin g th eir ultrast ru ctural 
mo rphology . In general, th e m ost strikin g m as t cell abnormality 
no ted has been an increase in th e number and len gth of cellular 
cyto plas m ic projections ' 8-1 2". Eva lu atio n of the cutaneo us m ast 
cell infi ltrates in o ur 3 patients w ith mastocy tosis confirmed the 
presence of these atyp ica l cell m embranc changes. H oweve r, we 
also observed that these lcsional sk in m as t cell s va ri ed from nor-
m al mast . cell s in th eir overa ll size and nuclear confI guration. 
Becausc of these atypica l m orp ho logic features, we questioned 
whether lesiona l m ast cells from o ur patien ts w ith mastocytoSis 
woul d res pond norm all y in vitro to d ifferent secreto ry agon ists. 
U sin g a techniqu e developed in o ur laboratory, we obta ined 
suspensions of m as t cell s fro m les io ns of m astocytosis w ith a 
purity of 2: 80%. When co mpared wi th normal skin specimens 
on a milli gram per wet weight bas is, lesions of m astocytosis 
yie lded approximately 7 t imes m ore m as t cells usin g this isolation 
procedure. It is of interest that we have observed sim ilar increases 
in m as t cell numbers above norm al controls in histologic sections 
of the te lan giectatic ma cules of m astocytosis [20]. 
T he in vitro fun ctional reactivities of m as tocytosis m as t cells 
to 2 different immunologic stimu li were exa mined. Despite ab-
no rm al cell surface m orpho logy , m astocytos is m as t cell s dem-
onstrated fu nctiona l recepto rs for th e an aph ylatox in C3, and for 
IgE antibod ies, and in general, the magnitude of these functional 
responses was at least equ al to normal skin m ast cell s. Both IgE 
antibodies and C3" are known to be im portant in vivo immu-
nologic agon ists for th e tissue m ast cell 116,21,221, and our ex-
periments in dica te that mast cell s in les ions of m astocytos is are 
ca pable of res ponding to these sti mul ato ry signals. 
Table I. In Vitro Stimulation o f Mast Cells Fro m Lesions o f Mastocytosis 
Histamine Content 
Skin Mast Per Mast Cell 
Cell Source (pg) 
Mastocytosis 4.2 (± 0 .6) 
Patient 1 
Mastocytosis 3.2 (± 0 . 1) 
Patient 2 
Mas tocytos is 3.3 (± 0.5) 
Patient 3 
Mean 3.6 (± 0 .3) 
N ormal skin '/ 4. 1 (± 0.8) 
,I n :;:::: J for each experim enta l condi tio n. 
' N I): not done. 
'Yo Histamine Release (± SE M )" 
Stimulus 
A23187 C3" 
Buffer (3 J.Lg/ ml) ( I J.LM ) 
8 .1 (± 1.2) 31. 8 (± 0.7) 22.7 (± 1.3) 
9.7 (± 4.3) 56.7 (± 5.4) 19.6 (± 1.3) 
12.8 (± 0 .8) 72.2 (± 4.5) ND 
10.1 (± \.7) 53.6 (± 8.7) 22.4 (± 1.3) 
7.5 (± 2.0) 39.5 (± 4.2) 19.0 (± 4.5) 
'Stilllubtion with mOLlse monoclona l antillumJu IgE Jntibod ies 3fter ovcmight sCllsitizJ tion with hUIl,"1l IgE (4.4 I1I g/ml). 
<In = I) fo r c;}ch cxpcrilll cIH31 condition. 
allti-lgE 
(1 J.Lg/ ml) 
NIY 
ND 
41.2 (± 6.0)' 
4 1. 2 (± 6.0) 
24.2 (± 2. 1)' 
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O u r s tudies also sh owed th at m astocytosis mast cells released 
hista min e fo ll owin g s timul a ti on w ith th e no nimJl1un o logic se-
c re tagogues, morphin e sul fa te and calcium io nop ho re A23 187. 
M o rphin e h as b een shown to indu ce in vitro histamin e release 
fro m no rm al skin mast ce lls but no t hum an periphera l blood 
basop hils [1 6,23,24]. In additi on , thi s o piate h as bcen reported to 
provoke epi sodes of cutan eous flu shin g and h ypotcns io n in pa-
tients followin g its parenteral administration as an anesthetic agent. 
A central ro le for m as t cell-derived his tamin e re lease in these 
reacti o ns ha s been s tron g ly sugges ted b y the obser va tion th at 
pretrea tm ent of patients with co mbin ed hi stamine, (H, ) and 
histam in e2 (H 2) recep tor antagonis ts sig nifi ca ntl y reduces the 
hemody na mi c ch anges indu ced b y m o rphine 125,26]. B eca use 
c utaneo us m as tocytos is m ast cells re lease his tamin e followin g ex-
pos ure to m o rphine in v itro, th e in vivo use of this agent and 
related co mpo und s in patients w ith mas tocytos is , co uld poten-
tia ll y indu ce sys temi c sym p to m s res ul ting fro m ma st cell de-
g ranulation . 
Calcium io no phore A23187 also is recognized as a m as t cell 
secre tagogue the effe ct of which is m ed ia ted primaril y by fac il-
ita ting the tran sportation of calcium in to the cell [27,28]. Ultra-
s tru ctural studies ha ve dem o ns trated that the m o rphologic changes 
that occur durin g A23187-induced m ast cell deg ranulation a re 
ver y simila r to th ose o bserved at the tim e o f an aph y la cti c mediator 
re lease [29,301. In o ur ex periments, 2 of the 3 patient m as t cell 
preparations showed an apparent aug mented res ponse to A23187 
w hen co mpared with no rm al cont ro ls. It is con ceivab le that skin 
mast cells from some pati ents with m astocytos is m ay h ave a defect 
in the regul ation of mediator release during a time of marked 
illtracellula r ca lcium influxes. H owever, the in vivo releva nce of 
th is in v itro obse rva ti o n remains un certain sin ce neithe r patient 
2 nor patient 3 ex perienced sig nifi ca nt cutaneous or sys temi c m ast 
cell-rela ted symptoms . 
Recent repo rts ha ve indicated that suspen sio ns of ca nin e m ast 
cells recovered from subcutaneo us m astocy tomas release media-
tors after in vitro stimulation with illlmuno logic and non im-
mu nologic agonis ts [31 ,32] ; however , the m agnitud e o f these 
responses has no t been correlated with norm al d og skin mas t 
cells. In this stud y we have demon strated tha t sus pen sions of 
human m as t cells can b e obta ined from papul:!r and telang iec tati c 
macul a r les ions o f ma stocy tosis as wel l as norm al s kin for in vitro 
fun ctio nal s tudies. In co ntras t to the well-differentiated dog mas-
tocy tos is m ast cell s, lesio nal skin m ast cells from o ur patients 
demonstra ted seve ral atypi ca l m o rph o log ic features, yet, w ere 
respo ns ive to both immuno logic and no niJl1munologic stimuli . 
T hus , w e co nclude frol11 this s tud y th at d es pite their morpholog ic 
a typia, Iesional skin m ast cells from o ur 3 mastocytosis pat ients 
had his tamine content very similar to normal cutaneous m ast cells 
and retained their functional reactivities to clinicall y relevant se-
cretor y agon ists. 
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